| Adverse effects of extradural and intrathecal opiates: report of a nationwide survey in Sweden LL Gustafsson, B Schildt, K Jacobsen British Journal of Anaesthesia 54 (5), 479-486, 1982 | 507 | 1982 |
| Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response HG Eichler, E Abadie, A Breckenridge, B Flamion, LL Gustafsson, ... Nature reviews Drug discovery 10 (7), 495-506, 2011 | 354 | 2011 |
| Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers J Adamski, B Godman, G Ofierska-Sujkowska, B Osińska, H Herholz, ... BMC health services research 10, 1-16, 2010 | 329 | 2010 |
| Present state of extradural and intrathecal opioid analgesia in Sweden: a nationwide follow-up survey N Rawal, S Arner, LL Gustafsson, R Allvin British Journal of Anaesthesia 59 (6), 791-799, 1987 | 309 | 1987 |
| The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm LL Gustafsson, B Wettermark, B Godman, E Andersén‐Karlsson, ... Basic & clinical pharmacology & toxicology 108 (4), 224-233, 2011 | 294 | 2011 |
| Disposition of chloroquine in man after single intravenous and oral doses. LL Gustafsson, O Walker, G Alvan, B Beermann, F Estevez, L Gleisner, ... British journal of clinical pharmacology 15 (4), 471-479, 1983 | 291 | 1983 |
| Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data XQ Li, A Björkman, TB Andersson, LL Gustafsson, CM Masimirembwa European journal of clinical pharmacology 59, 429-442, 2003 | 289 | 2003 |
| Clinical experience of long–term treatment with epidural and intrathecal opioids–a nationwide survey S Arner, N Rawal, LL Gustafsson Acta anaesthesiologica Scandinavica 32 (3), 253-259, 1988 | 230 | 1988 |
| Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010 | 205 | 2010 |
| Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants L Bertilsson, A Åberg-Wistedt, LL Gustafsson, C Nordin Therapeutic drug monitoring 7 (4), 478-480, 1985 | 192 | 1985 |
| SFINX—a drug-drug interaction database designed for clinical decision support systems Y Böttiger, K Laine, ML Andersson, T Korhonen, B Molin, ML Ovesjö, ... European journal of clinical pharmacology 65, 627-633, 2009 | 187 | 2009 |
| Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ... Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009 | 184 | 2009 |
| 4β-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians U Diczfalusy, J Miura, HK Roh, RA Mirghani, J Sayi, H Larsson, KG Bodin, ... Pharmacogenetics and genomics 18 (3), 201-208, 2008 | 169 | 2008 |
| Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ... Expert review of clinical pharmacology 8 (1), 77-94, 2015 | 164 | 2015 |
| Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania M Mubi, A Janson, M Warsame, A Mårtensson, K Källander, MG Petzold, ... PloS one 6 (7), e19753, 2011 | 164 | 2011 |
| Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ... Frontiers in pharmacology 5, 106, 2014 | 161 | 2014 |
| A novel polymorphism in ABCB1 gene, CYP2B6* 6 and sex predict single‐dose efavirenz population pharmacokinetics in Ugandans JK Mukonzo, D Röshammar, P Waako, M Andersson, T Fukasawa, ... British journal of clinical pharmacology 68 (5), 690-699, 2009 | 153 | 2009 |
| Policies to enhance prescribing efficiency in Europe: findings and future implications B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ... Frontiers in pharmacology 1, 141, 2011 | 151 | 2011 |
| Phenotype–genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles C Rodríguez-Antona, JG Sayi, LL Gustafsson, L Bertilsson, ... Biochemical and biophysical research communications 338 (1), 299-305, 2005 | 144 | 2005 |
| Central nervous system effects of subdissociative doses of (S)‐ketamine are related to plasma and brain concentrations measured with positron emission … P Hartvig, J Valtysson, KJ Lindner, J Kristensen, R Karlsten, ... Clinical Pharmacology & Therapeutics 58 (2), 165-173, 1995 | 138 | 1995 |
Brian GodmanKarolinska Institute, Strathclyde Institute of Pharmacy and Biomedical SciencesVerified email at briangodman.co.uk
